DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 990 filers reported holding DANAHER CORPORATION in Q3 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,899,454 | +2.2% | 7,656 | -1.1% | 0.16% | +8.7% |
| Q2 2023 | $1,857,840 | -5.1% | 7,741 | -0.4% | 0.15% | -14.8% |
| Q1 2023 | $1,958,099 | +94861.2% | 7,769 | 0.0% | 0.18% | -6.9% |
| Q4 2022 | $2,062 | -99.9% | 7,769 | -50.5% | 0.19% | -51.7% |
| Q3 2022 | $4,055,000 | +104.7% | 15,701 | +101.0% | 0.39% | +119.7% |
| Q2 2022 | $1,981,000 | -11.7% | 7,813 | +2.2% | 0.18% | +8.5% |
| Q1 2022 | $2,243,000 | -58.2% | 7,648 | -53.1% | 0.16% | -54.4% |
| Q4 2021 | $5,366,000 | -2.5% | 16,310 | -9.7% | 0.36% | -12.6% |
| Q3 2021 | $5,502,000 | +281.3% | 18,072 | +236.1% | 0.41% | +278.0% |
| Q2 2021 | $1,443,000 | +19.3% | 5,377 | 0.0% | 0.11% | +7.9% |
| Q1 2021 | $1,210,000 | -62.3% | 5,377 | -62.8% | 0.10% | -63.3% |
| Q4 2020 | $3,210,000 | -50.0% | 14,451 | -51.6% | 0.28% | -56.8% |
| Q3 2020 | $6,424,000 | +54.6% | 29,832 | +26.9% | 0.64% | +41.2% |
| Q2 2020 | $4,156,000 | +14.6% | 23,505 | -10.3% | 0.45% | -9.4% |
| Q1 2020 | $3,625,000 | +255.7% | 26,193 | +294.7% | 0.50% | +408.2% |
| Q4 2019 | $1,019,000 | +96.0% | 6,637 | +84.5% | 0.10% | +69.0% |
| Q3 2019 | $520,000 | +1.2% | 3,598 | 0.0% | 0.06% | +3.6% |
| Q2 2019 | $514,000 | -27.9% | 3,598 | -33.3% | 0.06% | -31.7% |
| Q1 2019 | $713,000 | -85.4% | 5,398 | -88.6% | 0.08% | -87.5% |
| Q4 2018 | $4,874,000 | +130.2% | 47,263 | +142.6% | 0.66% | +191.1% |
| Q3 2018 | $2,117,000 | +327.7% | 19,484 | +288.6% | 0.22% | +287.9% |
| Q2 2018 | $495,000 | +0.2% | 5,014 | -0.6% | 0.06% | -3.3% |
| Q1 2018 | $494,000 | -2.2% | 5,042 | +1.5% | 0.06% | +11.1% |
| Q4 2017 | $505,000 | +3.1% | 4,966 | -13.0% | 0.05% | -10.0% |
| Q3 2017 | $490,000 | +0.2% | 5,711 | -1.4% | 0.06% | -6.2% |
| Q2 2017 | $489,000 | +26.0% | 5,793 | +27.7% | 0.06% | +18.5% |
| Q1 2017 | $388,000 | +16.5% | 4,538 | +6.0% | 0.05% | +12.5% |
| Q4 2016 | $333,000 | -26.5% | 4,280 | -26.0% | 0.05% | -36.0% |
| Q3 2016 | $453,000 | -23.7% | 5,780 | -1.7% | 0.08% | -29.2% |
| Q2 2016 | $594,000 | +6.5% | 5,880 | 0.0% | 0.11% | +20.5% |
| Q1 2016 | $558,000 | +2.2% | 5,880 | 0.0% | 0.09% | +2.3% |
| Q4 2015 | $546,000 | +2.1% | 5,880 | -6.4% | 0.09% | -16.5% |
| Q3 2015 | $535,000 | – | 6,280 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |